Rapid Improvement in Function in Alzheimers After Enbrel Injection

This is a look at a small but fascinating studyTNF-alpha over activity is believed to play a role.
investigating a new treatment for Alzheimer'sDiseases such as psoriasis and Crohn's disease in
disease.Brains in Alzheimer's disease are damaged byaddition to rheumatoid arthritis are examples of
long term inflammation of the brain. The progressivediseases that etanercept is used.
deterioration in memory and ability to perform tasksA recent fascinating study from The Department of
that must have a functioning memory take theirNeurology, USC School of Medicine used injections of
gradual toll on these patients and their families. Severaletanercept(Enbrel) in the posterior neck. This location
million Americans are expected to be developof injection was used to improve delivery of the drug
Alzheimer's disease in the coming decades. Effectiveinto the brain, where it was hoped that its
treatments are currently poor and ineffective, so newanti-inflammatory activity would take effect. The study
treatments are crucial for the patients and theirincluded 15 patients who were injected weekly for six
families.months. Posterior neck injection of etanercept led to
Alzheimer's disease is a demntia resulting fromsustained cognitive improvement for these patients
inflammation and damagein the brain. The damage andwith Alzheimer's disease which ranged from mild to
inflammation occur due to a variety of chemicals thatsevere. Other recent studies have also supported the
the human body produces for other purposes. Oneidea that TNF plays a major part in the brain
specific chemical called TNF-alpha is thought to be ainflammation of Alzheimer's disease.
main cause of brain inflammation that occurs inThe study authors from Department of Neurology,
Alzheimer's disease. TNF-alpha is a protein moleculeUSC School of Medicine noted an unexpected and
made by white blood cells which stimulates anddramatic clinical result (which recurred in the majority of
activates the immune system in response to cancer orthe patients that were treated with etanercept ). The
some infections. Too much of this TNF-alphadramatic but repeatedly observed response was a
compound is believed to lead to immune systemnoticeable improvement within minutes of perispinal
diseases wherein the immune system attacks healthyetanercept injection. The rapid clinical improvement in
tissues, suchas joints(rheumatoid arthritis) ormemory and symptoms required the authors of the
skin(psoriasis). The newest treatments for thesestudy to add new testing procedures to their
diseases make use of drugs that stopTNF alphaprotocol-so that they could measure the
activity, thereby reducing undesirable inflammation.improvements.
Since 1998 etanercept(aka Enbrel), a potent TNFA case report of an elderly 81 year old man describes
blocking drug has been approved for human use, formarkedimprovement within 2 hours. The improvement
rheumatoid arthritis as the first official acceptedincluded the ability toremember interview details,
indication. Etanercept is now being used for aimprovement in ability to do simple calculations, ability to
numerous other diseases that involve excesss TNFbe better oriented to where he was and what time it
activity. Etanercept hooks on to TNF-alpha and stopswas. The man continued to show the improved level
TNF-alpha receptors on many cell surfaces. Thisof brain function including memory and performance of
blocking effect reduces the inflammatory effects oftasks throughout the duration study and in a 14 day
excess TNF-alpha. Researchers and physiciansfollow up period. Family members of the elderly patient
currently have extensive experience using etanerceptalso reported that they had noticed improvement in the
to treat a variety of inflammatory disorders wherepatient while at home.